Stada shareholders cautious on renewed Bain, Cinven bid
August 15, 2017
Drug Discovery | Bad Vilbel, Germany | Buyout
Retail stockholders of Stada have tendered fewer shares in the renewed offer for the drugmaker from Bain Capital and Cinven than at this point of the PE consortium's previous failed bid, per Reuters. The new proposal needs 63% of overall investor support to succeed but has won support from just over 34% of shareholders. The acceptance period for Bain and Cinven's updated €4.1 billion offer expires on Wednesday.